PMEF
RAIN

Point72 Middle East FZE’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Point72 Middle East FZE’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-132
Closed -$158 – 2001
2023
Q2 		$158 Buy
+132
New +$660 ﹤0.01% 1477

Other funds holding RAIN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Middle East FZE's RAIN Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Rain Oncology Inc. Common Stock (RAIN) in Q3 2023, closing a stake of 132 shares — an estimated $158 sold.

Point72 Middle East FZE first reported a position in RAIN in Q2 2023 and held it in 1 quarter. The position peaked at $158 in Q2 2023. 57 funds tracked by Wall St. Rank hold RAIN as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Rain Oncology Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 132 Rain Oncology Inc. Common Stock shares in Q3 2023, an estimated $158.
  • Point72 Middle East FZE first reported a position in Rain Oncology Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Rain Oncology Inc. Common Stock position peaked at $158 in Q2 2023.
  • 57 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.